J&J. Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York, October 15, 2015.
Lucas Jackson/Reuters
The deal must be accepted by 95% of the ovarian cancer claimants in state or federal court before it becomes final
NEW YORK,USA – Johnson & Johnson said on Monday, July 27, it would pay $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a chapter of contentious litigation that has dogged the company for years.
J&J said the settlement covers about 69,000 cases consolidated in federal court in New Jersey, and related cases in state court, totaling 99.75% of the remaining talc claims.
